4.7 Article

Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer

期刊

BRIEFINGS IN BIOINFORMATICS
卷 22, 期 3, 页码 -

出版社

OXFORD UNIV PRESS
DOI: 10.1093/bib/bbaa197

关键词

genomic selection; best linear unbiased prediction; HAT; multiomics data; prostate cancer; prognosis

资金

  1. UC Riverside Faculty Startup Fund
  2. UC Riverside Hellman Fellowship
  3. UC Academic Senate Regents
  4. UC Cancer Research Coordinating Committee Competition Award
  5. National Natural Science Foundation of China [81660426, 81873608, 81571427]
  6. National Key Basic Research Program of China [2015CB553706]
  7. Guangzhou Municipal Science and Technology Project [201803040001, 201707010291]

向作者/读者索取更多资源

This study utilized genomic selection and omics data, particularly the BLUP model and BLUP-HAT method, to predict the prognosis of prostate cancer. The results indicated that these methods performed well in increasing the reliability of outcome prediction.
Prognostic tests using expression profiles of several dozen genes help provide treatment choices for prostate cancer (PCa). However, these tests require improvement to meet the clinical need for resolving overtreatment, which continues to be a pervasive problem in PCa management. Genomic selection (GS) methodology, which utilizes whole-genome markers to predict agronomic traits, was adopted in this study for PCa prognosis. We leveraged The Cancer Genome Atlas (TCGA) database to evaluate the prediction performance of six GS methods and seven omics data combinations, which showed that the Best Linear Unbiased Prediction (BLUP) model outperformed the other methods regarding predictability and computational efficiency. Leveraging the BLUP-HAT method, an accelerated version of BLUP, we demonstrated that using expression data of a large number of disease-relevant genes and with an integration of other omics data (i.e. miRNAs) significantly increased outcome predictability when compared with panels consisting of a small number of genes. Finally, we developed a novel stepwise forward selection BLUP-HAT method to facilitate searching multiomics data for predictor variables with prognostic potential. The new method was applied to the TCGA data to derive mRNA and miRNA expression signatures for predicting relapse-free survival of PCa, which were validated in six independent cohorts. This is a transdisciplinary adoption of the highly efficient BLUP-HAT method and its derived algorithms to analyze multiomics data for PCa prognosis. The results demonstrated the efficacy and robustness of the new methodology in developing prognostic models in PCa, suggesting a potential utility in managing other types of cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据